Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1476, 2005-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Folate supplementation + methotrexate worthwhile in RA?
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
Access to resources
Recommend
TNF- inhibitors: `new era' of biological therapies for RA?
Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. :
Infliximab + methotrexate: the BeST induction therapy for early RA?
Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. :
Infliximab, etanercept worthwhile for RA in Spain?
Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. :
Are full or modified HAQ QOL questionnaires best in RA?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 318, 2001-01 ,pp. :